Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation

Blood

Volumn 97, Issue 11, 2001, Pages 3380-3389

  Storek, Jan ^a,b   Dawson, Monja A ^a   Storer, Barry ^a   Stevens Ayers, Terry ^a   Maloney, David G ^a   Marr, Kieren A ^a   Witherspoon, Robert P ^a   Bensinger, William ^a   Flowers, Mary E D ^a   Martin, Paul ^a   Storb, Rainer ^a   Appelbaum, Frederick R ^a   Boeckh, Michael ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; COTRIMOXAZOLE; FLUCONAZOLE; GANCICLOVIR; GLUCOCORTICOID; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; ITRACONAZOLE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PNEUMOCYSTIS PNEUMONIA; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME;

EID: 0035383814     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.11.3380     Document Type: Article

References (60)

1. Thomas ED, Blume KG, Forman SJ. Hematopoietic Cell Transplantation. 2nd ed. Malden, MA: Blackwell Science; 1999.
2. Atkinson K. Clinical Bone Marrow and Blood Stem Cell Transplantation. 2nd ed. Cambridge, United Kingdom: Cambridge University Press; 2000.
3. Atkinson K, Farewell V, Storb R, et al. Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. Blood. 1982;60:714-720.
4. Marks DI, Cullis JO, Ward KN, et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors: a comparison of complications in the first 2 years. Ann Intern Med. 1993;119:207-214.
5. Sullivan KM, Mori M, Sanders J, et al. Late complications of allogeneic and autologous marrow transplantation. Bone Marrow Transplant. 1992; 10(suppl 1):127-134.
6. Morrison VA, Haake RJ, Weisdorf DJ. Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome. Am J Med. 1994;96:497-503.
7. Ochs L, Shu XO, Miller J, et al. Late infections after allogeneic bone marrow transplantation: comparison of incidence in related and unrelated donor transplant recipients. Blood. 1995;86:3979-3986.
8. Storek J, Witherspoon RP. Immunologic reconstitution after hematopoietic stem cell transplantation. In: Atkinson K, ed. Clinical Bone Marrow and Blood Stem Cell Transplantation. Cambridge, United Kingdom: Cambridge University Press; 2000:111-146.
9. Small TN, Avigan D, Dupont B, et al. Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis. Biol Blood Marrow Transplant. 1997;3:65-75.
10. Storek J, Gooley T, Witherspoon RP, Sullivan KM, Storb R. Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. Am J Hematol. 1997;54:131-138.
11. Storek J, Espino G, Dawson MA, Storer B, Flowers MED, Maloney DG. Low B cell and monocyte counts on day 80 are associated with high infection rates between day 100 and 365 after allogeneic marrow transplantation. Blood. 2000;96: 3290-3293.
12. Ottinger HD, Beelen DW, Scheulen B, Schaefer UW, Grosse-Wilde H. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood. 1996; 88:2775-2779.
13. Storek J, Witherspoon RP, Maloney DG, Chauncey TR, Storb R. Improved reconstitution of CD4 T cells and B cells but worsened reconstitution of serum IgG levels after allogeneic transplantation of blood stem cells instead of marrow [letter]. Blood. 1997;89:3891-3893.
14. Hellerstein M, Hanley MB, Cesar D, et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med. 1999;5:83-89.
15. McLean AR, Michie CA. In vivo estimates of division and death rates of human T lymphocytes. Proc Natl Acad Sci U S A. 1995;92:3707-3711.
16. Michie CA, McLean A, Alcock C, Beverley PCL. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature. 1992;360:264-265.
17. Bensinger WI, Martin P, Storer B, et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med. 2001;344:175-181.
18. Storek J, Ferrara S, Ku N, Giorgi JV, Champlin RE, Saxon A. B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant. 1993;12: 387-398.
19. Storek J, Dawson MA, Maloney DG. Comparison of two flow cytometric methods enumerating CD4 T cells and CD8 T cells. Cytometry. 1998;33:76-82.
20. + B cells, the major B cell subset in the peripheral blood, express V-κ genes with no or little somatic mutation throughout life. Eur J Immunol. 1993;23:3272-3277.
21. Suzuki I, Milner ECB, Glas AM, et al. Immunoglobulin heavy chain variable region gene usage in bone marrow transplant recipients: lack of somatic mutation indicates a maturational arrest. Blood. 1996;87:1873-1880.
22. + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med. 1998;188:1679-1689.
23. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998;396: 690-695.
24. Dumont-Girard F, Roux E, van Lier RA, et al. Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants. Blood. 1998;92:4464-4471.
25. Storek J, Witherspoon RP, Storb R. T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant. 1995; 16:413-425.
26. + T cells contain cells with high levels of lymphocyte function-associated antigen-1 expression, a phenotype of primed T cells. J Immunol. 1993;150:429-437.
27. high T cell population. Eur J Immunol. 1993;23:1057-1063.
28. Chambers CA, Allison JP. Costimulatory regulation of T cell function. Curr Opin Cell Biol. 1999; 11:203-210.
29. Meyers JD, Flournoy N, Thomas ED. Infection with herpes simplex virus and cell-mediated immunity after marrow transplant. J Infect Dis. 1980;142:338-346.
30. Meyers JD, Flournoy N, Thomas ED. Cell-mediated immunity to varicella-zoster virus after allogeneic marrow transplant. J Infect Dis. 1980;141: 479-487.
31. Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med. 2000;342:844-850.
32. George AJ, Ritter MA. Thymic involution with ageing: obsolescence or good housekeeping? Immunol Today. 1996;17:267-272.
33. Fukushi N, Arase H, Wang B, et al. Thymus: a direct target tissue in graft-versus-host reaction after allogeneic bone marrow transplantation that results in abrogation of induction of self-tolerance. Proc Natl Acad Sci U S A. 1990;87:6301-6305.
34. Muller-Hermelink HK, Sale GE, Borisch B, Storb R. Pathology of the thymus after allogeneic bone marrow transplantation in man. Am J Pathol. 1987;129:242-256.
35. Ritter MA, Ladyman HM. The effects of cyclosporine on the thymic microenvironment and T cell development. In: Kendall MD, ed. Thymus Update Series 4. The Thymus in Immunotoxicology. Newark, NJ: Harwood Academic Press; 1991:157-176.
36. Holmes JA, Livesey SJ, Bedwell AE, Amos N, Whittaker JA. Autoantibody analysis in chronic GVHD. Bone Marrow Transplant. 1989;4:529-531.
37. Kier P, Penner E, Bakos S, et al. Autoantibodies in chronic GVHD: high prevalence of antinucleolar antibodies. Bone Marrow TranspJant. 1990;6: 93-96.
38. Sanmarco M, Vialettes B, Maraninchi D, Bernard D. Autoantibody formation after bone marrow transplantation: a comparison between autologous and allogeneic grafts. Autoimmunity. 1991; 11:7-12.
39. Lortan JE, Rochfort NC, el-Tumi M, Vellodi A. Autoantibodies after bone marrow transplantation in children with genetic disorders: relation to chronic graft-versus-host disease. Bone Marrow Transplant. 1992;9:325-330.
40. Smith CIE, Hammarstrom L, Lefvert AK. Bone marrow grafting induces acetylcholine receptor antibody formation [letter]. Lancet. 1985;1:978.
41. Soderberg C, Sumitran-Karuppan S, Ljungman P, Moller E. CD13-specific autoimmunity in cytomegalovirus-infected immunocompromised patients. Transplantation. 1996;61:594-600.
42. Soderberg C, Larsson S, Rozell BL, Sumitran-Karuppan S, Ljungman P, Moller E. Cytomegalovirus-induced CD13-specific autoimmunity-a possible cause of chronic GVHD. Transplantation. 1996;61:600-609.
43. Hebart H, Einsele H, Klein R, et al. CMV infection after allogeneic bone marrow transplantation is associated with the occurrence of various autoantibodies and monoclonal gammopathies. Brit J Haematol. 1996;95:138-144.
44. Mitus AJ, Stein R, Rappeport JM, et al. Monoclonal and oligoclonal gammopathy after bone marrow transplantation. Blood. 1989;74:2764-2768.
45. Fischer AM, Simon F, LeDeist F, Blanche S, Griscelli C, Fischer A. Prospective study of the occurrence of monoclonal gammapathies following bone marrow transplantation in young children. Transplantation. 1990;49:731-735.
46. Radl J, Liu M, Hoogeveen CM, et al. Monoclonal gammapathies in long-term surviving rhesus monkeys after lethal irradiation and bone marrow transplantation. Clin Immunol Immunopathol. 1991;60:305-309.
47. Tissot JD, Helg C, Chapuis B, et al. Clonal imbalances of serum immunoglobulins after allogeneic bone marrow transplantation: an analysis by high-resolution two-dimensional gel electrophoresis. Bone Marrow Transplant. 1992;10:347-353.
48. Mink JG, Radl J, VanDenBerg P, VanMuiswinkel WB, VanOosterom R. Homogenous immunoglobulins in the serum of irradiated and bone marrow reconstituted mice: the role of thymus and spleen. Immunology. 1979;37:889-894.
49. VanDenBerg P, Radl J, Lowenberg B, Swart ACW. Homogeneous antibodies in lethally irradiated and autologous bone marrow reconstituted Rhesus monkeys. Clin Exp Immunol. 1976;23: 355-359.
50. Gerritsen EJA, VanTol MJD, Ballieux P, et al. Search for the antigen specificity of homogeneous IgG components (H-IgG) after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1996;17:825-833.
51. Crabb JH, Finberg R, Onderdonk AB, Kasper DL. T cell regulation of Bacteroides fragilis-induced intraabdominal abscesses. Rev Infect Dis. 1990; 12(suppl 2):S178-S184.
52. Powderly WG, Schreiber JR, Pier GB, Markham RB. T cells recognizing polysaccharide-specific B cells function as contrasuppressor cells in the generation of T cell immunity to Pseudomonas aeruginosa. J Immunol. 1988;140:2746-2752.
53. Sieck TG, Moors MA, Buckley HR, Blank KJ. Protection against murine disseminated candidiasis mediated by a Candida albicans-specific T-cell line. Infect Immun. 1993;61:3540-3543.
54. Cenci E, Mencacci A, Bacci A, Bistoni F, Kurup VP, Romani L. T cell vaccination in mice with invasive pulmonary aspergillosis. J Immunol. 2000; 165:381-388.
55. Schmitz N, Beksac M, Hasenclever D, et al. A randomized study from the European Group for Blood and Marrow Transplantation comparing allogeneic transplantation of filgrastim-mobilized peripheral blood progenitor cells with bone marrow transplantation in 350 patients with leukemia [abstract]. Blood. 2000;96:477a.
56. Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin J. Incidence of acute and chronic GVHD after allogeneic peripheral blood stem cell and bone marrow transplantation: a meta-analysis [abstract]. Blood. 2000;96:205a.
57. Flowers MED, Matos A, Storer B, et al. Clinical manifestation of chronic GVHD after transplantation of peripheral blood stem cells compared to bone marrow [abstract]. Blood. 2000;96:203a.
58. Storb R, Deeg HJ, Whitehead J, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med. 1986;314:729-735.
59. Boeckh M, Gooley TA, Myerson D, Cunningham T, Schoch G, Bowden RA. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood. 1996;88:4063-4071.
60. Walter EA, Greenberg PD, Gilbert MJ, et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med. 1995;333:1038-1044.